Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sangbaipi decoction is a Traditional Chinese Medicine (TCM) formulation primarily derived from the root bark of *Morus alba* (Mulberry). It is traditionally used in Chinese medicine to clear heat from the lungs, relieve cough, and reduce edema. In clinical research conducted by Longhua Hospital, Shanghai University of Traditional Chinese Medicine, it is being evaluated for the treatment of bronchiectasis, specifically in patients with secondary colonization of multidrug-resistant *Pseudomonas aeruginosa* (MDR-PA). The decoction is often used in combination with other TCM formulations like Baozheng decoction to address specific TCM syndromes associated with chronic respiratory inflammation and bacterial colonization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sangbaipi decoction (Longhua Hospital Shanghai University of Traditional Chinese Medicine).